---
reference_id: "PMID:9220384"
title: Detection of parvovirus B19-specific IgM by antibody capture radioimmunoassay.
authors:
- Cohen BJ
journal: J Virol Methods
year: '1997'
doi: 10.1016/s0166-0934(97)00048-7
content_type: abstract_only
---

# Detection of parvovirus B19-specific IgM by antibody capture radioimmunoassay.
**Authors:** Cohen BJ
**Journal:** J Virol Methods (1997)
**DOI:** [10.1016/s0166-0934(97)00048-7](https://doi.org/10.1016/s0166-0934(97)00048-7)

## Content

1. J Virol Methods. 1997 Jun;66(1):1-4. doi: 10.1016/s0166-0934(97)00048-7.

Detection of parvovirus B19-specific IgM by antibody capture radioimmunoassay.

Cohen BJ(1).

Author information:
(1)Enteric and Respiratory Virus Laboratory, Central Public Health Laboratory, 
London, UK. bcohen@phls.co.uk

A solid phase IgM-capture radioimmunoassay (MACRIA) for the detection of 
parvovirus B19-IgM is described (Cohen et al., 1983, J. Hyg. Camb. 91, 113-130). 
IgM from a dilution of patients serum is 'captured' onto a solid phase coated by 
anti-human IgM. To determine whether any of the IgM is specific for parvovirus 
B19, B19 antigen is added followed by a detector system. In the MACRIA described 
here the detector system comprises a mouse monoclonal antibody to parvovirus B19 
and a 125I-labelled anti-mouse antibody. A calibration curve derived from a 
standard B19 IgM serum is used to quantify B19 IgM using a single dilution of 
test sera. The purpose of the protocol is the diagnosis of recent acute 
infection with parvovirus B19.

DOI: 10.1016/s0166-0934(97)00048-7
PMID: 9220384 [Indexed for MEDLINE]